Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
By L. H. Kuller, R. Tracy, W. Belloso, S. D. Wit, F. Drummond, H. Lane, B. Ledergerber, J. Lundgren, Jacqueline Neuhaus, D. Nixon and 2 more. PLoS Medicine, 2008
1,638 citations recorded by the source corpus.
Background In the Strategies for Management of Anti-Retroviral Therapy trial, all-cause mortality was higher for participants randomized to intermittent, CD4-guided antiretroviral treatment (ART) (drug conservation [DC]) than continuous ART (viral suppression [VS]). We hypothesized that increased HIV-RNA levels following ART interruption induced activation of tissue factor pathways, thrombosis, and fibrinolysis. Methods and Findings Stored samples were used to measure six biomarkers: high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), amyloid A, amyloid P, D-dimer, and prothrombin fragment 1+2. Two studies were conducted: (1) a nested case–control study for studying biomarker associations with mortality, and (2) a study to compare DC and VS participants for biomarker changes. For (1), markers were determined at study entry and before death (latest level) for 85 deaths and for two controls (n = 170) matched on country, age, sex, and date of randomization. Odds ratios (ORs) were estimated with logistic regression. For each biomarker, each of the three upper quartiles was compared to the lowest quartile. For (2), the biomarkers were assessed for 249 DC and 250 VS participants at study entry and 1 mo following randomization. Higher levels of hsCRP, IL-6, and D-dimer at study entry were significantly associated with an increased risk of all-cause mortality. Unadjusted ORs (highest versus lowest quartile) were 2.0 (95% confidence interval [CI], 1.0–4.1; p = 0.05), 8.3 (95% CI, 3.3–20.8; p < 0.0001), and 12.4 (95% CI, 4.2–37.0; p < 0.0001), respectively. Associations were significant after adjustment, when the DC and VS groups were analyzed separately, and when latest levels were assessed. IL-6 and D-dimer increased at 1 mo by 30% and 16% in the DC group and by 0% and 5% in the VS group (p < 0.0001 for treatment difference for both biomarkers); increases in the DC group were related to HIV-RNA levels at 1 mo (p < 0.0001). In an expanded case–control analysis (four controls per case), the OR (DC/VS) for mortality was reduced from 1.8 (95% CI, 1.1–3.1; p = 0.02) to 1.5 (95% CI, 0.8–2.8) and 1.4 (95% CI, 0.8–2.5) after adjustment for latest levels of IL-6 and D-dimer, respectively. Conclusions IL-6 and D-dimer were strongly related to all-cause mortality. Interrupting ART may further increase the risk of death by raising IL-6 and D-dimer levels. Therapies that reduce the inflammatory response to HIV and decrease IL-6 and D-dimer levels may warrant investigation. Trial Registration: ClinicalTrials.gov (NCT00027352).
Subfields: Emergency Medicine, Infectious Diseases, Virology
View Paper: https://www.semanticscholar.org/paper/2fa1b34361cc4b79223215343e57eb23d79ddbdb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Virology
Citations in the corpus
- Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. (2014, background): “HIV infection is associated with inflammation, innate immune activation, and altered coagulation [37–39], which are generally considered important drivers for comorbidity in both HIV-uninfected and HIV-infected individuals [15, 16, 40, 41].”
- Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging (2018, methodology): “Mortality and age-associated co-morbidities among HIV+ individuals track with plasma inflammatory and coagulation markers, such as C-reactive protein (CRP), IL-6, D-dimer, and fibrinogen [9-14], similar to the general population [15-21].”
- Markers of Inflammation, Coagulation and Renal Function Are Elevated in Adults with HIV Infection (2010, background): “hsCRP, IL-6, D-dimer, and cystatin C levels were measured at baseline in a subset of the randomized participants [3, 7].”
- HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity (2009, background): “Although the epidemiology and pathogenesis of HIV associated cardiovascular disease are complex and controversial, two consistent trends have emerged. Firstly, the risk of cardiovascular events is higher in untreated than treated HIV infection, probably because inflammation is increased in untreated”
- Plasma levels of soluble CD14 independently predict mortality in HIV infection. (2011, background): “To make use of biomarkers already measured on stored samples [20–22], matching paralleled that of other nested case-control studies for this cohort, with subjects matched for age (within 5 years), sex, country, and date of enrollment (within 3 months) [20].”
- Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study (2015, methodology): “Increased levels of the inflammatory markers IL-6 and hs-CRP and the coagulation marker Ddimer have been shown to be associated with increased morbidity and mortality in ART treated HIV-1 infected individuals [24, 26].”
- HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality (2014, background): “While the mechanisms driving the increased burden of agingassociated disease in HIV-infected individuals are not fully understood, an emerging body of evidence suggests that persistent innate and adaptive immune dysfunction and/or activation are major risk factors [9–12].”